Innovations in Diabetes Cure, Safer CAR-T Therapy, and Pediatric Genetic Disease Treatment

Share this:
Published: 29 Jun 2018

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across diabetes care, CAR-T cell therapy, pedriatic and genetic disease treatment. Novel solutions for pancreatic islet transplants, CAR-T cell therapy, enzyme replacement therapy, and autism correlations are profiled. Clinical trials scenario for Alzheimer's disease is also depicted. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Diabetes, CAR-T therapy, pediatrics, genetic disease treatment, pancreatic islet transplant, enzyme replacement therapy, fatal genetic disorder, autism, recombinant drugs, Alzheimer’s disease



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..